This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Sahil Khanna: Innovator in Predicting Infection Treatment Outcomes
Introduction
Sahil Khanna is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in understanding and predicting treatment outcomes for infections.
Latest Patents
Sahil Khanna holds a patent for "Biomarkers for predicting infection treatment outcome." This patent provides biomarkers that can be altered in the gut of a mammal suffering from Clostridium difficile infection (CDI). The biomarkers can be utilized to predict the treatment outcome for CDI, including the response to primary treatment and the risk of recurrence. The methods outlined in the patent offer innovative approaches to predicting treatment responses and recurrence risks in mammals, including humans.
Career Highlights
Sahil Khanna is associated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in the medical field. His work focuses on improving patient outcomes through innovative biomarker research.
Collaborations
Sahil collaborates with esteemed colleagues such as Darrell S. Pardi and Purna C. Kashyap, contributing to a rich environment of medical research and innovation.
Conclusion
Sahil Khanna's work in developing biomarkers for predicting infection treatment outcomes represents a significant advancement in medical research. His contributions are poised to enhance the understanding and management of CDI, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile